Quantcast

Posts related to ‘Pharmaceuticals’

Wall St Bull statue

Key Changes Made on the UBS Key Call List (UBS, WCRX, STZ, BUD)

Posted: February 15, 2013 at 10:00 am

We wrote at great length last month about the Key Call and Conviction Buy lists from the major Wall St. firms, bulge bracket and otherwise. The reason these lists are ...
Read Full Story »
Pills

Forest Labs Sputters on Patent Expiration

Posted: January 15, 2013 at 7:44 am

Forest Laboratories Inc. (NYSE: FRX) reported third-quarter fiscal 2013 results before markets opened this morning. The drug maker and marketer reported an adjusted diluted earnings per share (EPS) loss of ...
Read Full Story »
pills

Drug Maker Staging a Comeback After Yesterday’s Debacle

Posted: December 14, 2012 at 11:54 am

Drug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment it was developing with AstraZeneca plc (NYSE: AZN) did not ...
Read Full Story »
pills

Amarin Takes on More Debt, Shares Suffer

Posted: December 7, 2012 at 9:21 am

Biopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in nonequity financing from an investment fund managed by Pharmakon Advisors. ...
Read Full Story »

Criminal Charges in Drug Insider Trading Scheme

Posted: November 20, 2012 at 11:25 am

The U.S. Securities and Exchange Commission (SEC) today filed criminal charges against a former SAC Capital Advisors hedge-fund manager related to an insider trading scheme that generated profits and avoided ...
Read Full Story »

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: November 12, 2012 at 8:04 am

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »

Cell Therapeutics Collapses on Secondary Offering

Posted: October 5, 2012 at 8:13 am

Biopharmaceutical firm Cell Therapeutics Inc. (NASDAQ: CTIC) announced a secondary offering this morning of 60,000 shares of its Series 17 preferred stock at a price of $1,000.00 per share: Each ...
Read Full Story »

Companies That Will Not Be Hurt by the Fiscal Cliff

Posted: September 27, 2012 at 6:32 am

The fiscal cliff has been described as a potential disaster for the finances of individuals and corporations alike. If Congress and the White House do not reach an agreement on ...
Read Full Story »

No News is Good News — Peregrine Pharma

Posted: September 25, 2012 at 12:06 pm

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data reported on the company’s Phase II trial of its lung-cancer ...
Read Full Story »

Peregrine Pharma Collapses on News of Data Errors

Posted: September 24, 2012 at 11:12 am

Just over two weeks ago Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported a statistically significant improvement in the company’s bavituximab lung-cancer treatment. Shares jumped nearly 50% and eventually posted at more ...
Read Full Story »

Anti-obesity Drug Likely to Be Rejected in Europe — Vivus

Posted: September 21, 2012 at 9:16 am

U.S. drugmaker Vivus Inc. (NASDAQ: VVUS) announced this morning that the company had been notified that its anti-obesity drug, Qsiva, is not likely to be approved for use in the ...
Read Full Story »

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: September 13, 2012 at 8:52 am

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the ...
Read Full Story »

American Companies with the Most Cash

Posted: September 13, 2012 at 6:41 am

While many individual Americans are struggling financially, some of the largest corporations in the United States are sitting on billions in cash. Moody’s pointed out in March that U.S. nonfinancial companies' cash holdings ...
Read Full Story »

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Posted: August 27, 2012 at 8:10 am

The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the ...
Read Full Story »

Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)

Posted: August 24, 2012 at 8:04 am

Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in recently completed ...
Read Full Story »